| Sharon Kaye Joiner, MD | |
|
309 Jackson St., Monroe, LA 71201-7407 | |
| (318) 966-4541 | |
| (318) 966-4543 |
| Full Name | Sharon Kaye Joiner |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 35 Years |
| Location | 309 Jackson St., Monroe, Louisiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578508487 | NPI | - | NPPES |
| 1650447 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 020436 (Louisiana) | Secondary |
| 207R00000X | Internal Medicine | 020436 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Louisiana Hospice And Palliative Care | Monroe, LA | Hospice |
| St Francis Medical Center | Monroe, LA | Hospital |
| Mercy Regional Medical Center | Ville platte, LA | Hospital |
| Northern Louisiana Medical Center | Ruston, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Emergency Group Of St Landry Llc | 0749237212 | 8 |
| St Francis Medical Group Llc | 5092970624 | 122 |
News Archive
New data presented at the American Association for Cancer Research's Seventh Annual International Frontiers in Cancer Prevention Research meeting outlines new data, which assesses breast cancer risk among women with a strong family history of breast cancer, but without a BRCA1 or BRCA2 mutation.
Republicans unveiled what they've termed the "Health Care Bill of Right for Seniors" Monday in an attempt to tailor their messages to the elderly, The Washington Post reports.
Tackling antibiotic resistance on only one front is a waste of time because resistant genes are freely crossing environmental, agricultural and clinical boundaries, new research has shown.
Postgraduate training in a wide range of engineering and scientific fields important to the UK's economy received a further boost today. Twenty two new Centres for Doctoral Training (CDTs) were announced by the Chancellor of the Exchequer, The Rt. Hon George Osborne MP.
Salix Pharmaceuticals, Ltd. today announced that the Company has submitted an efficacy supplement to NDA 21-361 for XIFAXAN® (rifaximin) 550 mg tablets for the proposed indication of treatment of non-constipation irritable bowel syndrome (Non-C IBS) and IBS-related bloating.
› Verified 4 days ago
| Entity Name | St Francis Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437149168 PECOS PAC ID: 7810892718 Enrollment ID: O20031204000183 |
News Archive
New data presented at the American Association for Cancer Research's Seventh Annual International Frontiers in Cancer Prevention Research meeting outlines new data, which assesses breast cancer risk among women with a strong family history of breast cancer, but without a BRCA1 or BRCA2 mutation.
Republicans unveiled what they've termed the "Health Care Bill of Right for Seniors" Monday in an attempt to tailor their messages to the elderly, The Washington Post reports.
Tackling antibiotic resistance on only one front is a waste of time because resistant genes are freely crossing environmental, agricultural and clinical boundaries, new research has shown.
Postgraduate training in a wide range of engineering and scientific fields important to the UK's economy received a further boost today. Twenty two new Centres for Doctoral Training (CDTs) were announced by the Chancellor of the Exchequer, The Rt. Hon George Osborne MP.
Salix Pharmaceuticals, Ltd. today announced that the Company has submitted an efficacy supplement to NDA 21-361 for XIFAXAN® (rifaximin) 550 mg tablets for the proposed indication of treatment of non-constipation irritable bowel syndrome (Non-C IBS) and IBS-related bloating.
› Verified 4 days ago
| Entity Name | Emergency Group Of St Landry Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164491320 PECOS PAC ID: 0749237212 Enrollment ID: O20050406000828 |
News Archive
New data presented at the American Association for Cancer Research's Seventh Annual International Frontiers in Cancer Prevention Research meeting outlines new data, which assesses breast cancer risk among women with a strong family history of breast cancer, but without a BRCA1 or BRCA2 mutation.
Republicans unveiled what they've termed the "Health Care Bill of Right for Seniors" Monday in an attempt to tailor their messages to the elderly, The Washington Post reports.
Tackling antibiotic resistance on only one front is a waste of time because resistant genes are freely crossing environmental, agricultural and clinical boundaries, new research has shown.
Postgraduate training in a wide range of engineering and scientific fields important to the UK's economy received a further boost today. Twenty two new Centres for Doctoral Training (CDTs) were announced by the Chancellor of the Exchequer, The Rt. Hon George Osborne MP.
Salix Pharmaceuticals, Ltd. today announced that the Company has submitted an efficacy supplement to NDA 21-361 for XIFAXAN® (rifaximin) 550 mg tablets for the proposed indication of treatment of non-constipation irritable bowel syndrome (Non-C IBS) and IBS-related bloating.
› Verified 4 days ago
| Entity Name | Emergency Staffing Solutions Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477590974 PECOS PAC ID: 9830001650 Enrollment ID: O20050610000177 |
News Archive
New data presented at the American Association for Cancer Research's Seventh Annual International Frontiers in Cancer Prevention Research meeting outlines new data, which assesses breast cancer risk among women with a strong family history of breast cancer, but without a BRCA1 or BRCA2 mutation.
Republicans unveiled what they've termed the "Health Care Bill of Right for Seniors" Monday in an attempt to tailor their messages to the elderly, The Washington Post reports.
Tackling antibiotic resistance on only one front is a waste of time because resistant genes are freely crossing environmental, agricultural and clinical boundaries, new research has shown.
Postgraduate training in a wide range of engineering and scientific fields important to the UK's economy received a further boost today. Twenty two new Centres for Doctoral Training (CDTs) were announced by the Chancellor of the Exchequer, The Rt. Hon George Osborne MP.
Salix Pharmaceuticals, Ltd. today announced that the Company has submitted an efficacy supplement to NDA 21-361 for XIFAXAN® (rifaximin) 550 mg tablets for the proposed indication of treatment of non-constipation irritable bowel syndrome (Non-C IBS) and IBS-related bloating.
› Verified 4 days ago
| Entity Name | Webster Emergency Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245209527 PECOS PAC ID: 2961448170 Enrollment ID: O20050628000996 |
News Archive
New data presented at the American Association for Cancer Research's Seventh Annual International Frontiers in Cancer Prevention Research meeting outlines new data, which assesses breast cancer risk among women with a strong family history of breast cancer, but without a BRCA1 or BRCA2 mutation.
Republicans unveiled what they've termed the "Health Care Bill of Right for Seniors" Monday in an attempt to tailor their messages to the elderly, The Washington Post reports.
Tackling antibiotic resistance on only one front is a waste of time because resistant genes are freely crossing environmental, agricultural and clinical boundaries, new research has shown.
Postgraduate training in a wide range of engineering and scientific fields important to the UK's economy received a further boost today. Twenty two new Centres for Doctoral Training (CDTs) were announced by the Chancellor of the Exchequer, The Rt. Hon George Osborne MP.
Salix Pharmaceuticals, Ltd. today announced that the Company has submitted an efficacy supplement to NDA 21-361 for XIFAXAN® (rifaximin) 550 mg tablets for the proposed indication of treatment of non-constipation irritable bowel syndrome (Non-C IBS) and IBS-related bloating.
› Verified 4 days ago
| Entity Name | Northern Louisiana Emergency Physicians, Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588828172 PECOS PAC ID: 9638246846 Enrollment ID: O20080930000036 |
News Archive
New data presented at the American Association for Cancer Research's Seventh Annual International Frontiers in Cancer Prevention Research meeting outlines new data, which assesses breast cancer risk among women with a strong family history of breast cancer, but without a BRCA1 or BRCA2 mutation.
Republicans unveiled what they've termed the "Health Care Bill of Right for Seniors" Monday in an attempt to tailor their messages to the elderly, The Washington Post reports.
Tackling antibiotic resistance on only one front is a waste of time because resistant genes are freely crossing environmental, agricultural and clinical boundaries, new research has shown.
Postgraduate training in a wide range of engineering and scientific fields important to the UK's economy received a further boost today. Twenty two new Centres for Doctoral Training (CDTs) were announced by the Chancellor of the Exchequer, The Rt. Hon George Osborne MP.
Salix Pharmaceuticals, Ltd. today announced that the Company has submitted an efficacy supplement to NDA 21-361 for XIFAXAN® (rifaximin) 550 mg tablets for the proposed indication of treatment of non-constipation irritable bowel syndrome (Non-C IBS) and IBS-related bloating.
› Verified 4 days ago
| Entity Name | Northern Louisiana Emergency Physicians, Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598995847 PECOS PAC ID: 9638246846 Enrollment ID: O20090903000029 |
News Archive
New data presented at the American Association for Cancer Research's Seventh Annual International Frontiers in Cancer Prevention Research meeting outlines new data, which assesses breast cancer risk among women with a strong family history of breast cancer, but without a BRCA1 or BRCA2 mutation.
Republicans unveiled what they've termed the "Health Care Bill of Right for Seniors" Monday in an attempt to tailor their messages to the elderly, The Washington Post reports.
Tackling antibiotic resistance on only one front is a waste of time because resistant genes are freely crossing environmental, agricultural and clinical boundaries, new research has shown.
Postgraduate training in a wide range of engineering and scientific fields important to the UK's economy received a further boost today. Twenty two new Centres for Doctoral Training (CDTs) were announced by the Chancellor of the Exchequer, The Rt. Hon George Osborne MP.
Salix Pharmaceuticals, Ltd. today announced that the Company has submitted an efficacy supplement to NDA 21-361 for XIFAXAN® (rifaximin) 550 mg tablets for the proposed indication of treatment of non-constipation irritable bowel syndrome (Non-C IBS) and IBS-related bloating.
› Verified 4 days ago
| Entity Name | St Francis Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134405087 PECOS PAC ID: 5092970624 Enrollment ID: O20120706000094 |
News Archive
New data presented at the American Association for Cancer Research's Seventh Annual International Frontiers in Cancer Prevention Research meeting outlines new data, which assesses breast cancer risk among women with a strong family history of breast cancer, but without a BRCA1 or BRCA2 mutation.
Republicans unveiled what they've termed the "Health Care Bill of Right for Seniors" Monday in an attempt to tailor their messages to the elderly, The Washington Post reports.
Tackling antibiotic resistance on only one front is a waste of time because resistant genes are freely crossing environmental, agricultural and clinical boundaries, new research has shown.
Postgraduate training in a wide range of engineering and scientific fields important to the UK's economy received a further boost today. Twenty two new Centres for Doctoral Training (CDTs) were announced by the Chancellor of the Exchequer, The Rt. Hon George Osborne MP.
Salix Pharmaceuticals, Ltd. today announced that the Company has submitted an efficacy supplement to NDA 21-361 for XIFAXAN® (rifaximin) 550 mg tablets for the proposed indication of treatment of non-constipation irritable bowel syndrome (Non-C IBS) and IBS-related bloating.
› Verified 4 days ago
| Entity Name | Island Medical Sp, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295080869 PECOS PAC ID: 2365690286 Enrollment ID: O20120919000345 |
News Archive
New data presented at the American Association for Cancer Research's Seventh Annual International Frontiers in Cancer Prevention Research meeting outlines new data, which assesses breast cancer risk among women with a strong family history of breast cancer, but without a BRCA1 or BRCA2 mutation.
Republicans unveiled what they've termed the "Health Care Bill of Right for Seniors" Monday in an attempt to tailor their messages to the elderly, The Washington Post reports.
Tackling antibiotic resistance on only one front is a waste of time because resistant genes are freely crossing environmental, agricultural and clinical boundaries, new research has shown.
Postgraduate training in a wide range of engineering and scientific fields important to the UK's economy received a further boost today. Twenty two new Centres for Doctoral Training (CDTs) were announced by the Chancellor of the Exchequer, The Rt. Hon George Osborne MP.
Salix Pharmaceuticals, Ltd. today announced that the Company has submitted an efficacy supplement to NDA 21-361 for XIFAXAN® (rifaximin) 550 mg tablets for the proposed indication of treatment of non-constipation irritable bowel syndrome (Non-C IBS) and IBS-related bloating.
› Verified 4 days ago
| Entity Name | Monroe Emergency Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386235331 PECOS PAC ID: 8820405079 Enrollment ID: O20210406000374 |
News Archive
New data presented at the American Association for Cancer Research's Seventh Annual International Frontiers in Cancer Prevention Research meeting outlines new data, which assesses breast cancer risk among women with a strong family history of breast cancer, but without a BRCA1 or BRCA2 mutation.
Republicans unveiled what they've termed the "Health Care Bill of Right for Seniors" Monday in an attempt to tailor their messages to the elderly, The Washington Post reports.
Tackling antibiotic resistance on only one front is a waste of time because resistant genes are freely crossing environmental, agricultural and clinical boundaries, new research has shown.
Postgraduate training in a wide range of engineering and scientific fields important to the UK's economy received a further boost today. Twenty two new Centres for Doctoral Training (CDTs) were announced by the Chancellor of the Exchequer, The Rt. Hon George Osborne MP.
Salix Pharmaceuticals, Ltd. today announced that the Company has submitted an efficacy supplement to NDA 21-361 for XIFAXAN® (rifaximin) 550 mg tablets for the proposed indication of treatment of non-constipation irritable bowel syndrome (Non-C IBS) and IBS-related bloating.
› Verified 4 days ago
| Entity Name | Ess Of Ferriday Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346900560 PECOS PAC ID: 2769876275 Enrollment ID: O20220228000365 |
News Archive
New data presented at the American Association for Cancer Research's Seventh Annual International Frontiers in Cancer Prevention Research meeting outlines new data, which assesses breast cancer risk among women with a strong family history of breast cancer, but without a BRCA1 or BRCA2 mutation.
Republicans unveiled what they've termed the "Health Care Bill of Right for Seniors" Monday in an attempt to tailor their messages to the elderly, The Washington Post reports.
Tackling antibiotic resistance on only one front is a waste of time because resistant genes are freely crossing environmental, agricultural and clinical boundaries, new research has shown.
Postgraduate training in a wide range of engineering and scientific fields important to the UK's economy received a further boost today. Twenty two new Centres for Doctoral Training (CDTs) were announced by the Chancellor of the Exchequer, The Rt. Hon George Osborne MP.
Salix Pharmaceuticals, Ltd. today announced that the Company has submitted an efficacy supplement to NDA 21-361 for XIFAXAN® (rifaximin) 550 mg tablets for the proposed indication of treatment of non-constipation irritable bowel syndrome (Non-C IBS) and IBS-related bloating.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sharon Kaye Joiner, MD 5959 S Sherwood Forest Blvd, Baton Rouge, LA 70816-6038 Ph: (318) 966-4541 | Sharon Kaye Joiner, MD 309 Jackson St., Monroe, LA 71201-7407 Ph: (318) 966-4541 |
News Archive
New data presented at the American Association for Cancer Research's Seventh Annual International Frontiers in Cancer Prevention Research meeting outlines new data, which assesses breast cancer risk among women with a strong family history of breast cancer, but without a BRCA1 or BRCA2 mutation.
Republicans unveiled what they've termed the "Health Care Bill of Right for Seniors" Monday in an attempt to tailor their messages to the elderly, The Washington Post reports.
Tackling antibiotic resistance on only one front is a waste of time because resistant genes are freely crossing environmental, agricultural and clinical boundaries, new research has shown.
Postgraduate training in a wide range of engineering and scientific fields important to the UK's economy received a further boost today. Twenty two new Centres for Doctoral Training (CDTs) were announced by the Chancellor of the Exchequer, The Rt. Hon George Osborne MP.
Salix Pharmaceuticals, Ltd. today announced that the Company has submitted an efficacy supplement to NDA 21-361 for XIFAXAN® (rifaximin) 550 mg tablets for the proposed indication of treatment of non-constipation irritable bowel syndrome (Non-C IBS) and IBS-related bloating.
› Verified 4 days ago
Arthur Eldridge Richert, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 611 Grammont St., Monroe, LA 71201 Phone: 318-325-2634 Fax: 318-812-1205 | |
Richard Van Vines Ii, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 920 Oliver Road, Suite A, Monroe, LA 71201 Phone: 318-329-9202 Fax: 318-329-9202 | |
James Thomas Rittelmeyer, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1100 N 18th St Ste 100, Monroe, LA 71201 Phone: 318-361-9900 Fax: 318-361-0428 | |
Mr. Praneet Sivaramakrishnan Iyer, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4864 Jackson St, Monroe, LA 71202 Phone: 318-330-7000 | |
Dr. Charles Ujay Gbadouwey, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 309 Jackson St, Monroe, LA 71201 Phone: 318-966-4541 Fax: 318-966-4543 | |
Kelvin C Wade, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 401 Hall St Ste A, Monroe, LA 71201 Phone: 318-324-9113 Fax: 318-329-9382 | |
Dr. Nkeekam O Anumele, M.D., PHARM D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 711 Wood St, Ste A, Monroe, LA 71201 Phone: 318-323-8847 Fax: 318-327-3410 |